Co‐designing a behavioural intervention for reducing the impact of chemotherapy‐induced peripheral neuropathy symptoms: An evidence‐ and theory‐driven approach
| Autor: | Mary Anne Lagmay Tanay, Jose Roca, Catherine Oakley, Rona Moss-Morris, Glenn Robert, Jo Armes, Liz Bryson, Deb Tanner, Toni Wyatt, Lesley Sage, Robin Johnston, Anne Marie Rafferty, Lauren Urwin |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | European Journal of Cancer Care. 31 |
| ISSN: | 1365-2354 0961-5423 |
| DOI: | 10.1111/ecc.13671 |
| Popis: | PurposeThe processes and mechanisms of action which explain how behavioural interventions for chemotherapy-induced peripheral neuropathy (CIPN) work or not are unclear. We describe a co-design process for developing an evidence and theory-based behavioural intervention to reduce the impact of CIPN symptoms on patients’ quality of life.Methods Guided by the Medical Research Council Framework for developing and evaluating complex interventions, our process of intervention development was informed by: (a) findings of systematic reviews, (b) inductive analysis of thirty-nine hours of observational fieldwork, twelve patient and eleven clinician interviews, (c) deductive analysis using the Common-Sense Self-Regulation Model and (d) fifteen patients and twenty clinicians being actively involved as co-designers. ResultsCIPN perception and coping behaviours (including, for example, self-monitoring of symptoms and engaging in self-management and safety strategies to reduce impact of CIPN symptoms) were highlighted as processes to target when co-designing an intervention. To address these behaviours, a psychoeducational approach was deemed suitable. Four behavioural change techniques informed the co-design of the intervention: (a) information about health consequences, (b) salience of consequences, (c) instruction on how to perform a behaviour and (d) action planning.ConclusionCurrent behavioural interventions for CIPN have rarely involved stakeholders, e.g. patients and clinicians, in their development process. We developed a logic model for documenting the proposed mechanism of action of our co-designed intervention for reducing impact of CIPN symptoms. This model will be refined and tested in a subsequent process evaluation as part of a feasibility trial of the intervention. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|